Erythropoietin as candidate for supportive treatment of severe COVID-19
Sign Up to like & getrecommendations! Published in 2020 at "Molecular Medicine"
DOI: 10.1186/s10020-020-00186-y
Abstract: In light of the present therapeutic situation in COVID-19, any measure to improve course and outcome of seriously affected individuals is of utmost importance. We recap here evidence that supports the use of human recombinant… read more here.
Keywords: erythropoietin; erythropoietin candidate; supportive treatment; covid ... See more keywords